CFRXQ
ContraFect Corp

8,196
Loading...
Loading...
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of ContraFect Corp?
What is the 52-week high for ContraFect Corp?
What is the 52-week low for ContraFect Corp?
What is ContraFect Corp stock price today?
What was ContraFect Corp stock price yesterday?
What is the 50-day moving average of ContraFect Corp?

Latest CFRXQ News

View
No CFRXQ news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.